| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 731266 | 86056 | METAMIZOL MABO 575 mg CAPSULAS DURAS EFG | METAMIZOL MABO 575 mg CAPSULAS DURAS EFG, 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86056/86056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86056/86056_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2021-07-01 | 1 | 1 | 1 | 2021-07-02 | 2021-07-01 | 0 | 2021-07-27 | View Edit Delete | ||||||||||||
| 731494 | 61563 | LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61563/61563_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61563/61563_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-11-08 | 1 | 1 | 1 | 2001-11-08 | 2021-08-09 | 1 | 2023-04-21 | View Edit Delete | ||||||||||||
| 731495 | 61568 | LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LAMICTAL 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61568/61568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61568/61568_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-11-08 | 1 | 1 | 1 | 2001-11-08 | 2021-08-09 | 1 | 2023-04-21 | View Edit Delete | ||||||||||||
| 731557 | 61569 | LAMICTAL 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LAMICTAL 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61569/61569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61569/61569_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 2021-08-27 | 1 | 2023-07-14 | View Edit Delete | ||||||||||||
| 731558 | 61562 | LAMICTAL 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LAMICTAL 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61562/61562_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61562/61562_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-11-08 | 1 | 1 | 1 | 2001-11-08 | 2021-08-27 | 1 | 2023-04-21 | View Edit Delete | ||||||||||||
| 731559 | 64464 | CRISOMET 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | CRISOMET 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64464/64464_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64464/64464_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-12-18 | 1 | 1 | 1 | 2001-12-18 | 2021-08-27 | 1 | 2023-07-14 | View Edit Delete | ||||||||||||
| 731560 | 64462 | CRISOMET 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | CRISOMET 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64462/64462_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64462/64462_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-12-18 | 1 | 1 | 1 | 2001-12-18 | 2021-08-27 | 1 | 2023-08-11 | View Edit Delete | ||||||||||||
| 731563 | 63747 | CRISOMET 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | CRISOMET 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63747/63747_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63747/63747_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-03-19 | 1 | 1 | 1 | 2001-03-19 | 2021-08-27 | 1 | 2023-10-09 | View Edit Delete | ||||||||||||
| 731566 | 65284 | LABILENO 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LABILENO 50 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 50 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65284/65284_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65284/65284_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2003-03-18 | 1 | 1 | 1 | 2003-03-18 | 2021-08-27 | 1 | 2023-04-21 | View Edit Delete | ||||||||||||
| 731567 | 63288 | LABILENO 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LABILENO 25 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 25 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63288/63288_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63288/63288_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2000-07-26 | 1 | 1 | 1 | 2000-07-26 | 2021-08-27 | 1 | 2023-04-21 | View Edit Delete | ||||||||||||
| 731568 | 64943 | LABILENO 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LABILENO 100 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64943/64943_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64943/64943_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2002-07-26 | 1 | 1 | 1 | 2002-07-26 | 2021-08-27 | 1 | 2023-07-14 | View Edit Delete | ||||||||||||
| 731573 | 64463 | CRISOMET 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | CRISOMET 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64463/64463_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64463/64463_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-12-18 | 1 | 1 | 1 | 2001-12-18 | 2021-09-09 | 1 | 2023-08-11 | View Edit Delete | ||||||||||||
| 731574 | 65283 | LABILENO 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES | LABILENO 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65283/65283_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65283/65283_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2003-03-18 | 1 | 1 | 1 | 2003-03-18 | 2021-09-09 | 1 | 2023-08-11 | View Edit Delete | ||||||||||||
| 730904 | 85946 | BUTILESCOPOLAMINA AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS EFG | BUTILESCOPOLAMINA AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS EFG, 60 comprimidos | 10 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85946/85946_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85946/85946_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2021-04-23 | 1 | 1 | 1 | 2021-04-24 | 2021-04-23 | 1 | 2022-03-07 | View Edit Delete | ||||||||||||
| 731065 | 85984 | LACOSAMIDA AUROVITAS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA AUROVITAS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 100 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85984/85984_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85984/85984_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 731066 | 85985 | LACOSAMIDA AUROVITAS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA AUROVITAS 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 150 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85985/85985_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85985/85985_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 731068 | 85986 | LACOSAMIDA AUROVITAS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA AUROVITAS 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 200 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85986/85986_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85986/85986_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 731069 | 85987 | LACOSAMIDA AUROVITAS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACOSAMIDA AUROVITAS 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 50 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85987/85987_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85987/85987_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 731276 | 1211556001 | ONUREG 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONUREG 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 7 comprimidos | 200 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211556001/1211556001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211556001/1211556001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2021-07-22 | 1 | 1 | 1 | 2021-07-23 | 2021-07-22 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 731277 | 1211556003 | ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONUREG 300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 7 comprimidos | 300 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211556003/1211556003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211556003/1211556003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2021-07-22 | 1 | 1 | 1 | 2021-07-23 | 2021-07-22 | 1 | 2023-03-13 | View Edit Delete |
Page 254 of 1036, showing 20 records out of 20709 total, starting on record 5061, ending on 5080